je.st
news
Investment Analysts' Weekly Ratings Updates for Inogen
2015-08-24 09:54:21| Biotech - Topix.net
They now have a $58.00 price target on the stock. According to Zacks, "Inogen's unique direct-to-customer business model, innovative product suite and growing patient base are key growth catalysts in our view.
Tags: ratings
updates
investment
weekly
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||